Morse Asset Management, Inc Jazz Pharmaceuticals PLC Transaction History

Morse Asset Management, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$125.55 - $144.48 $677,970 - $780,192	-5,400 Closed	0 $0
Q1 2019 May 02, 2019	SELL	$121.81 - $142.95 $73,086 - $85,770	-600 Reduced 10.0%	5,400 $772,000
Q4 2018 Feb 13, 2019	SELL	$115.94 - $166.74 $1.58 Million - $2.27 Million	-13,620 Reduced 69.42%	6,000 $744,000
Q3 2018 Nov 01, 2018	SELL	$161.01 - $180.57 $36,227 - $40,628	-225 Reduced 1.13%	19,620 $3.3 Million
Q2 2018 Aug 15, 2018	SELL	$146.33 - $183.18 $39,509 - $49,458	-270 Reduced 1.34%	19,845 $3.42 Million
Q1 2018 May 02, 2018	SELL	$135.59 - $157.16 $186,436 - $216,095	-1,375 Reduced 6.4%	20,115 $3.04 Million
Q4 2017 Jan 29, 2018	SELL	$131.06 - $150.39 $795,534 - $912,867	-6,070 Reduced 22.02%	21,490 $2.89 Million
Q3 2017 Oct 31, 2017	BUY	$142.62 - $155.6 $3.93 Million - $4.29 Million	27,560	27,560 $4.03 Million

527

58M

173K

110K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8.58B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Morse Asset Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Morse Asset Management, Inc with notifications on news.